Analyze Diet
Vector borne and zoonotic diseases (Larchmont, N.Y.)2010; 10(7); 659-664; doi: 10.1089/vbz.2009.0230

West Nile virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in southern Africa.

Abstract: West Nile virus (WNV) is widely distributed in South Africa, but since a few cases of neurological disease have been reported from this region, endemic lineage 2 strains were postulated to be of low virulence. Several cases of nonfatal encephalitis in humans as well as fatal cases in a foal, dog, and ostrich chicks have, however, been associated with lineage 2 WNV in South Africa. The pathogenesis of lineage 2 WNV strains was investigated using mouse neuroinvasive experiments, gene expression experiments, and genome sequence comparisons which indicated that lineage 2 strains that are highly pathogenic exist. To determine whether cases of WNV were being missed in South Africa, horses with fever and neurological disease were investigated. Several cases of WNV were identified, all associated with severe neurological disease, 85% of which had to be euthanized or died. All cases positive by RT-PCR were shown to belong to lineage 2 WNV by DNA sequencing and phylogenetic analysis. Two cases of occupational infection were investigated, including a case of zoonotic transmission to a veterinarian who performed an autopsy on one of the horses as well as a laboratory infection after a needle stick injury with a neuroinvasive lineage 2 strain. Both resulted in neurological disease. Cytokine expression was investigated in the second case to assess the immunopathogenesis of WNV. Collectively, these studies suggest that lineage 2 WNV may be significantly under estimated as a cause of neurological disease in South Africa.
Publication Date: 2010-09-22 PubMed ID: 20854018DOI: 10.1089/vbz.2009.0230Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research highlights that West Nile Virus (WNV), particularly of the lineage 2 strain, is a cause of severe neurological disease in both humans and horses in South Africa. Despite previous assumptions about lower virulence, cases of WNV related diseases have been identified, pointing to an underscoring of the impact of lineage 2 WNV in the region.

Research Objectives and Approach

  • The research set out to investigate the pathogenesis of lineage 2 WNV strains in South Africa, given few reported cases, implying a low virulence perception.
  • The methods involved conducting neuroinvasive experiments on mice, gene expression studies and genome sequence comparisons.
  • Through this multifaceted approach, they aimed to uncover the potential virulence and prevalence of lineage 2 WNV in the region.

Findings on WNV in Horses

  • The research further explored cases of WNV in horses presenting with fever and neurological disease, revealing several instances of WNV, all affiliated with severe neurological conditions.
  • Most of the affected horses (85%) had to be euthanized or died due to the disease severity.
  • DNA sequencing and phylogenetic analysis confirmed all RT-PCR-positive cases to be lineage 2 WNV.

Evidence of Zoonotic Transmission

  • In addition to equine cases, the study also looked into two occupational infection incidents to understand more about zoonotic transmission of the virus.
  • Both cases examined were those of a veterinarian who performed an autopsy on one of the affected horses and a laboratory infection following a needle stick injury with a neuroinvasive lineage 2 strain.
  • Both incidents had resulted in neurological disease in the human subjects, therefore depicting a clear risk of transmission between animals and humans.

Implications of the Findings

  • The study’s findings suggest a potentially wider prevalence and higher virulence of lineage 2 WNV within the South African region than previously esteemed.
  • By confirming the severity of neurological diseases caused by this strain, the research underscores the importance of accurate diagnosis and prevention measures in both animals and humans.

Cite This Article

APA
Venter M, Swanepoel R. (2010). West Nile virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in southern Africa. Vector Borne Zoonotic Dis, 10(7), 659-664. https://doi.org/10.1089/vbz.2009.0230

Publication

ISSN: 1557-7759
NlmUniqueID: 100965525
Country: United States
Language: English
Volume: 10
Issue: 7
Pages: 659-664

Researcher Affiliations

Venter, Marietjie
  • Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. marietjiev@nicd.ac.za
Swanepoel, Robert

    MeSH Terms

    • Animals
    • Female
    • Horse Diseases / epidemiology
    • Horse Diseases / virology
    • Horses
    • Humans
    • Male
    • Mice
    • Needlestick Injuries
    • South Africa / epidemiology
    • Virulence
    • West Nile Fever / epidemiology
    • West Nile Fever / veterinary
    • West Nile Fever / virology
    • West Nile virus / genetics
    • West Nile virus / pathogenicity
    • Zoonoses

    Citations

    This article has been cited 40 times.
    1. Mancuso E, Cecere JG, Iapaolo F, Di Gennaro A, Sacchi M, Savini G, Spina F, Monaco F. West Nile and Usutu Virus Introduction via Migratory Birds: A Retrospective Analysis in Italy.. Viruses 2022 Feb 17;14(2).
      doi: 10.3390/v14020416pubmed: 35216009google scholar: lookup
    2. Mencattelli G, Iapaolo F, Monaco F, Fusco G, de Martinis C, Portanti O, Di Gennaro A, Curini V, Polci A, Berjaoui S, Di Felice E, Rosà R, Rizzoli A, Savini G. West Nile Virus Lineage 1 in Italy: Newly Introduced or a Re-Occurrence of a Previously Circulating Strain?. Viruses 2021 Dec 30;14(1).
      doi: 10.3390/v14010064pubmed: 35062268google scholar: lookup
    3. Guggemos HD, Fendt M, Hieke C, Heyde V, Mfune JKE, Borgemeister C, Junglen S. Simultaneous circulation of two West Nile virus lineage 2 clades and Bagaza virus in the Zambezi region, Namibia.. PLoS Negl Trop Dis 2021 Apr;15(4):e0009311.
      doi: 10.1371/journal.pntd.0009311pubmed: 33798192google scholar: lookup
    4. Bertram FM, Thompson PN, Venter M. Epidemiology and Clinical Presentation of West Nile Virus Infection in Horses in South Africa, 2016-2017.. Pathogens 2020 Dec 30;10(1).
      doi: 10.3390/pathogens10010020pubmed: 33396935google scholar: lookup
    5. Fiacre L, Pagès N, Albina E, Richardson J, Lecollinet S, Gonzalez G. Molecular Determinants of West Nile Virus Virulence and Pathogenesis in Vertebrate and Invertebrate Hosts.. Int J Mol Sci 2020 Nov 30;21(23).
      doi: 10.3390/ijms21239117pubmed: 33266206google scholar: lookup
    6. Chauhan RP, Dessie ZG, Noreddin A, El Zowalaty ME. Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.. Pathogens 2020 Apr 20;9(4).
      doi: 10.3390/pathogens9040301pubmed: 32325980google scholar: lookup
    7. Sack A, Oladunni FS, Gonchigoo B, Chambers TM, Gray GC. Zoonotic Diseases from Horses: A Systematic Review.. Vector Borne Zoonotic Dis 2020 Jul;20(7):484-495.
      doi: 10.1089/vbz.2019.2541pubmed: 32077811google scholar: lookup
    8. Kain MP, Bolker BM. Predicting West Nile virus transmission in North American bird communities using phylogenetic mixed effects models and eBird citizen science data.. Parasit Vectors 2019 Aug 8;12(1):395.
      doi: 10.1186/s13071-019-3656-8pubmed: 31395085google scholar: lookup
    9. Vonesch N, Binazzi A, Bonafede M, Melis P, Ruggieri A, Iavicoli S, Tomao P. Emerging zoonotic viral infections of occupational health importance.. Pathog Dis 2019 Mar 1;77(2).
      doi: 10.1093/femspd/ftz018pubmed: 30916772google scholar: lookup
    10. Kolawole OM, Seriki AA, Irekeola AA, Ogah JI. The Neglect and Fast Spread of Some Arboviruses: A Note for Healthcare Providers in Nigeria.. Diseases 2018 Nov 5;6(4).
      doi: 10.3390/diseases6040099pubmed: 30400643google scholar: lookup
    11. Romo H, Papa A, Kading R, Clark R, Delorey M, Brault AC. Comparative Vector Competence of North American Culex pipiens and Culex quinquefasciatus for African and European Lineage 2 West Nile Viruses.. Am J Trop Med Hyg 2018 Jun;98(6):1863-1869.
      doi: 10.4269/ajtmh.17-0935pubmed: 29637885google scholar: lookup
    12. Braack L, Gouveia de Almeida AP, Cornel AJ, Swanepoel R, de Jager C. Mosquito-borne arboviruses of African origin: review of key viruses and vectors.. Parasit Vectors 2018 Jan 9;11(1):29.
      doi: 10.1186/s13071-017-2559-9pubmed: 29316963google scholar: lookup
    13. Tantely LM, Cêtre-Sossah C, Rakotondranaivo T, Cardinale E, Boyer S. Population dynamics of mosquito species in a West Nile virus endemic area in Madagascar.. Parasite 2017;24:3.
      doi: 10.1051/parasite/2017005pubmed: 28134093google scholar: lookup
    14. Mentoor JL, Lubisi AB, Gerdes T, Human S, Williams JH, Venter M. Full-Genome Sequence of a Neuroinvasive West Nile Virus Lineage 2 Strain from a Fatal Horse Infection in South Africa.. Genome Announc 2016 Jul 28;4(4).
      doi: 10.1128/genomeA.00740-16pubmed: 27469963google scholar: lookup
    15. Patsoula E, Vakali A, Balatsos G, Pervanidou D, Beleri S, Tegos N, Baka A, Spanakos G, Georgakopoulou T, Tserkezou P, Van Bortel W, Zeller H, Menounos P, Kremastinou J, Hadjichristodoulou C. West Nile Virus Circulation in Mosquitoes in Greece (2010-2013).. Biomed Res Int 2016;2016:2450682.
      doi: 10.1155/2016/2450682pubmed: 27294111google scholar: lookup
    16. Plante JA, Torres M, Huang CY, Beasley DWC. Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.. Virology 2016 Sep;496:97-105.
      doi: 10.1016/j.virol.2016.05.024pubmed: 27284640google scholar: lookup
    17. Szentpáli-Gavallér K, Lim SM, Dencső L, Bányai K, Koraka P, Osterhaus AD, Martina BE, Bakonyi T, Bálint Á. In Vitro and in Vivo Evaluation of Mutations in the NS Region of Lineage 2 West Nile Virus Associated with Neuroinvasiveness in a Mammalian Model.. Viruses 2016 Feb 19;8(2).
      doi: 10.3390/v8020049pubmed: 26907325google scholar: lookup
    18. Van Hoeven N, Joshi SW, Nana GI, Bosco-Lauth A, Fox C, Bowen RA, Clements DE, Martyak T, Parks DE, Baldwin S, Reed SG, Coler RN. A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.. PLoS One 2016;11(2):e0149610.
      doi: 10.1371/journal.pone.0149610pubmed: 26901122google scholar: lookup
    19. Chancey C, Grinev A, Volkova E, Rios M. The global ecology and epidemiology of West Nile virus.. Biomed Res Int 2015;2015:376230.
      doi: 10.1155/2015/376230pubmed: 25866777google scholar: lookup
    20. Hernández-Triana LM, Jeffries CL, Mansfield KL, Carnell G, Fooks AR, Johnson N. Emergence of west nile virus lineage 2 in europe: a review on the introduction and spread of a mosquito-borne disease.. Front Public Health 2014;2:271.
      doi: 10.3389/fpubh.2014.00271pubmed: 25538937google scholar: lookup
    21. Lwande OW, Venter M, Lutomiah J, Michuki G, Rumberia C, Gakuya F, Obanda V, Tigoi C, Odhiambo C, Nindo F, Symekher S, Sang R. Whole genome phylogenetic investigation of a West Nile virus strain isolated from a tick sampled from livestock in north eastern Kenya.. Parasit Vectors 2014 Nov 28;7:542.
      doi: 10.1186/s13071-014-0542-2pubmed: 25430727google scholar: lookup
    22. Merino-Ramos T, Blázquez AB, Escribano-Romero E, Cañas-Arranz R, Sobrino F, Saiz JC, Martín-Acebes MA. Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus.. PLoS One 2014;9(9):e108056.
      doi: 10.1371/journal.pone.0108056pubmed: 25229345google scholar: lookup
    23. van Eeden C, Swanepoel R, Venter M. Antibodies against West Nile and Shuni Viruses in Veterinarians, South Africa.. Emerg Infect Dis 2014 Aug;20(8):1409-11.
      doi: 10.3201/eid2008.131724pubmed: 25062350google scholar: lookup
    24. Langevin SA, Bowen RA, Reisen WK, Andrade CC, Ramey WN, Maharaj PD, Anishchenko M, Kenney JL, Duggal NK, Romo H, Bera AK, Sanders TA, Bosco-Lauth A, Smith JL, Kuhn R, Brault AC. Host competence and helicase activity differences exhibited by West Nile viral variants expressing NS3-249 amino acid polymorphisms.. PLoS One 2014;9(6):e100802.
      doi: 10.1371/journal.pone.0100802pubmed: 24971589google scholar: lookup
    25. Hoover LI, Fredericksen BL. IFN-dependent and -independent reduction in West Nile virus infectivity in human dermal fibroblasts.. Viruses 2014 Mar 24;6(3):1424-41.
      doi: 10.3390/v6031424pubmed: 24662674google scholar: lookup
    26. Mulatti P, Mazzucato M, Montarsi F, Ciocchetta S, Capelli G, Bonfanti L, Marangon S. Retrospective space-time analysis methods to support West Nile virus surveillance activities.. Epidemiol Infect 2015 Jan;143(1):202-13.
      doi: 10.1017/S0950268814000442pubmed: 24641869google scholar: lookup
    27. Marka A, Diamantidis A, Papa A, Valiakos G, Chaintoutis SC, Doukas D, Tserkezou P, Giannakopoulos A, Papaspyropoulos K, Patsoula E, Badieritakis E, Baka A, Tseroni M, Pervanidou D, Papadopoulos NT, Koliopoulos G, Tontis D, Dovas CI, Billinis C, Tsakris A, Kremastinou J, Hadjichristodoulou C, Vakalis N, Vassalou E, Zarzani S, Zounos A, Komata K, Balatsos G, Beleri S, Mpimpa A, Papavasilopoulos V, Rodis I, Spanakos G, Tegos N, Spyrou V, Dalabiras Z, Birtsas P, Athanasiou L, Papanastassopoulou M, Ioannou C, Athanasiou C, Gerofotis C, Papadopoulou E, Testa T, Tsakalidou O, Rachiotis G, Bitsolas N, Mamouris Z, Moutou K, Sarafidou T, Stamatis K, Sarri K, Tsiodras S, Georgakopoulou T, Detsis M, Mavrouli M, Stavropoulou A, Politi L, Mageira G, Christopoulou V, Diamantopoulou G, Spanakis N, Vrioni G, Piperaki ET, Mitsopoulou K, Kioulos I, Michaelakis A, Stathis I, Tselentis I, Psaroulaki A, Keramarou M, Chochlakis D, Photis Y, Konstantinou M, Manetos P, Tsobanoglou S, Mourelatos S, Antalis V, Pergantas P, Eleftheriou G. West Nile virus state of the art report of MALWEST Project.. Int J Environ Res Public Health 2013 Dec 2;10(12):6534-610.
      doi: 10.3390/ijerph10126534pubmed: 24317379google scholar: lookup
    28. Donadieu E, Bahuon C, Lowenski S, Zientara S, Coulpier M, Lecollinet S. Differential virulence and pathogenesis of West Nile viruses.. Viruses 2013 Nov 22;5(11):2856-80.
      doi: 10.3390/v5112856pubmed: 24284878google scholar: lookup
    29. Ladbury GA, Gavana M, Danis K, Papa A, Papamichail D, Mourelatos S, Gewehr S, Theocharopoulos G, Bonovas S, Benos A, Panagiotopoulos T. Population seroprevalence study after a West Nile virus lineage 2 epidemic, Greece, 2010.. PLoS One 2013;8(11):e80432.
      doi: 10.1371/journal.pone.0080432pubmed: 24260390google scholar: lookup
    30. Pauli G, Bauerfeind U, Blümel J, Burger R, Drosten C, Gröner A, Gürtler L, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Seitz R, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H. West nile virus.. Transfus Med Hemother 2013 Aug;40(4):265-84.
      doi: 10.1159/000353698pubmed: 24179475google scholar: lookup
    31. Martín-Acebes MA, Saiz JC. West Nile virus: A re-emerging pathogen revisited.. World J Virol 2012 Apr 12;1(2):51-70.
      doi: 10.5501/wjv.v1.i2.51pubmed: 24175211google scholar: lookup
    32. Barzon L, Papa A, Pacenti M, Franchin E, Lavezzo E, Squarzon L, Masi G, Martello T, Testa T, Cusinato R, Palù G. Genome sequencing of West Nile Virus from human cases in Greece, 2012.. Viruses 2013 Sep 24;5(9):2311-9.
      doi: 10.3390/v5092311pubmed: 24064795google scholar: lookup
    33. Lim SM, Koraka P, van Boheemen S, Roose JM, Jaarsma D, van de Vijver DA, Osterhaus AD, Martina BE. Characterization of the mouse neuroinvasiveness of selected European strains of West Nile virus.. PLoS One 2013;8(9):e74575.
      doi: 10.1371/journal.pone.0074575pubmed: 24058590google scholar: lookup
    34. Angenvoort J, Brault AC, Bowen RA, Groschup MH. West Nile viral infection of equids.. Vet Microbiol 2013 Nov 29;167(1-2):168-80.
      doi: 10.1016/j.vetmic.2013.08.013pubmed: 24035480google scholar: lookup
    35. Scherbik SV, Pulit-Penaloza JA, Basu M, Courtney SC, Brinton MA. Increased early RNA replication by chimeric West Nile virus W956IC leads to IPS-1-mediated activation of NF-κB and insufficient virus-mediated counteraction of the resulting canonical type I interferon signaling.. J Virol 2013 Jul;87(14):7952-65.
      doi: 10.1128/JVI.02842-12pubmed: 23678179google scholar: lookup
    36. Zaayman D, Venter M. West Nile virus neurologic disease in humans, South Africa, September 2008-may 2009.. Emerg Infect Dis 2012 Dec;18(12):2051-4.
      doi: 10.3201/eid1812.111208pubmed: 23171668google scholar: lookup
    37. van Eeden C, Williams JH, Gerdes TG, van Wilpe E, Viljoen A, Swanepoel R, Venter M. Shuni virus as cause of neurologic disease in horses.. Emerg Infect Dis 2012 Feb;18(2):318-21.
      doi: 10.3201/eid1802.111403pubmed: 22305525google scholar: lookup
    38. Pesko KN, Ebel GD. West Nile virus population genetics and evolution.. Infect Genet Evol 2012 Mar;12(2):181-90.
      doi: 10.1016/j.meegid.2011.11.014pubmed: 22226703google scholar: lookup
    39. Venter M, Human S, van Niekerk S, Williams J, van Eeden C, Freeman F. Fatal neurologic disease and abortion in mare infected with lineage 1 West Nile virus, South Africa.. Emerg Infect Dis 2011 Aug;17(8):1534-6.
      doi: 10.3201/eid1708.101794pubmed: 21801644google scholar: lookup
    40. Papa A, Bakonyi T, Xanthopoulou K, Vázquez A, Tenorio A, Nowotny N. Genetic characterization of West Nile virus lineage 2, Greece, 2010.. Emerg Infect Dis 2011 May;17(5):920-2.
      doi: 10.3201/eid1705.101759pubmed: 21529413google scholar: lookup